NFKB1 and Alzheimer disease: As previously mentioned, an increase in Aβ release is thought to promote wakefulness (Musiek et al., 2015; Vanderheyden et al., 2018), raising the possibility that AA-mediated activation of NF-κB further perpetuates sleep disturbances in AD.